Works by Langley, Brett C.

Results: 2
    1

    Mithramycin Is a Gene-Selective Sp1 Inhibitor That Identifies a Biological Intersection between Cancer and Neurodegeneration.

    Published in:
    Journal of Neuroscience, 2011, v. 31, n. 18, p. 6858, doi. 10.1523/JNEUROSCI.0710-11.2011
    By:
    • Sleiman, Sama F.;
    • Langley, Brett C.;
    • Basso, Manuela;
    • Berlin, Jill;
    • Li Xia;
    • Payappilly, Jimmy B.;
    • Kharel, Madan K.;
    • Hengchang Guo;
    • Marsh, J. Lawrence;
    • Thompson, Leslie Michels;
    • Mahishi, Lata;
    • Ahuja, Preeti;
    • MacLellan, W. Robb;
    • Geschwind, Daniel H.;
    • Coppola, Giovanni;
    • Rohr, Jürgen;
    • Ratan, Rajiv R.
    Publication type:
    Article
    2

    Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease.

    Published in:
    EMBO Molecular Medicine, 2010, v. 2, n. 9, p. 349, doi. 10.1002/emmm.201000084
    By:
    • McConoughey, Stephen J.;
    • Basso, Manuela;
    • Niatsetskaya, Zoya V.;
    • Sleiman, Sama F.;
    • Smirnova, Natalia A.;
    • Langley, Brett C.;
    • Mahishi, Lata;
    • Cooper, Arthur J. L.;
    • Antonyak, Marc A.;
    • Cerione, Rick A.;
    • Li, Bo;
    • Starkov, Anatoly;
    • Chaturvedi, Rajnish Kumar;
    • Beal, M. Flint;
    • Coppola, Giovanni;
    • Geschwind, Daniel H.;
    • Ryu, Hoon;
    • Xia, Li;
    • Iismaa, Siiri E.;
    • Pallos, Judit
    Publication type:
    Article